The abstract is read at the publisher; the summary is JClub's.
A 4-gene whole-blood panel (PSTPIP2, CLIC4, CACNB4, GZMK) distinguishes pediatric Crohn’s disease from disorders of gut-brain interaction with AUC up to 0.96 internally.
- Why it matters: Overlapping symptoms often require endoscopy to tell Crohn’s disease from disorders of gut-brain interaction, and clinicians need a blood-based way to prioritize who should undergo invasive testing.
- What they did: In a prospective two-center cohort of 425 treatment-naive participants aged 5–25 years, whole-blood RNA sequencing was modeled for diagnosis and, within Crohn’s disease, for Pediatric Crohn’s Disease Activity Index, then distilled into a 4-gene network-derived panel.
- The result: The panel achieved up to 0.93 AUC externally and up to 0.95 specificity and 0.93 positive predictive value, and its Crohn’s activity-linked signature reflects neutrophil/platelet activation and lymphocyte depletion.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.